Τόμος 24 (2010) – Τεύχος 3 – Άρθρο 4 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 24 (2010) – Issue 3 – Article 4 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

1. Department of Pharmacology, Medical School, Kapodestrian University of Athens, Athens, Hellas

2. Department of Cardiothoracic Anaesthesia and Intensive Care, James Cook University Hospital, Marton Road, Middlesbrough TS4 3BW, UK

pharmakonpress[at]pharmakonpress[.]gr

2. Olsen H., Andersen A., Nordbø A., Kongsgaard U.E., Børmer O.P.: Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro. BMC Clin. Pharmacol. 4: 4 (2004)

3. Sudlow G., Birkett D.J., Wade D.N.: The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 11: 824-832 (1975)

4. Wanwimorluk S., Birkett D.J., Brooks P.M.: Structural requirements for drug binding to site II on human serum albumin. Mol. Pharmacol. 24: 458-463 (1983)

5. Wosilait W.D., Ryan M.P.: The effects of oleic acid, tolbutamide, and oxyphenbutazone on the binding of warfarin by human serum albumin. Res. Commun. Chem. Pathol. Pharmacol. 25: 577-584 (1979)

6. Rahim S., Aubry A.F.: Location of binding sites on immobilized human serum albumin for some nonsteroidal anti-inflammatory drugs. J. Pharm. Sci. 84: 949-952 (1995)

7. Chan T.Y.: Adverse interactions between warfarin and nonsteroidal antiinflammatory drugs: mechanisms, clinical significance, and avoidance. Ann. Pharmacother. 29: 1274-1283 (1995); Comment in: Ann. Pharmacother. 29: 1289-1291 (1995)

8. Huang B.X., Dass C., Kim H.Y.: Probing conformational changes of human serum albumin due to unsaturated fatty acid binding by chemical cross-linking and mass spectrometry. Biochem. J. 387(Pt 3): 695-702 (2005)

9. Alevizou A., Kotsiou A.: The role of drug-binding in the current therapy. Rev. Clin. Pharmacol. Pharmacokinet., Int. Ed. 22 (Suppl. 2): 383-388 (2008)

10. Tawara S., Matsumoto S., Matsumoto Y., Kamimura T., Goto S.: Structure-binding relationship and binding sites of cephalosporins in human serum albumin. J. Antibiot. 45: 1346-1357 (1992)

11. Kotsiou A., Diamanti E., Potamianou A., Parara H., Vovou J., Perisanidis C., Tesseromatis C.: Anticoagulantinduced changes on antibiotic concentrations in the serum and bones. Eur. J. Drug Metabol. Pharmacokinet. 33: 173-179 (2008)

12. Speight T.M., Holford N.H.G.: Avery‘s Drug Treatment. 4th Edition, p. 1647, Adis International, Barcelona, 1997

13. Tsivou E., Melakopoulos I., Kotsiou A., Anagnostopoulou S., Tesseromatis C.: Alterations in cefalosporin levels in the serum and mandible of hyperlipaedemic rats after co-administration of ibuprofen. Eur. J. Drug Metabol. Pharmacokinet. 30: 171-174 (2005)

14. Tigka E., Daskala I., Rallis G., Anagnostopoulou S., Tesseromatis C.: Adjuvant arthritis-induced changes on ampicillin binding in serum and tissues under the influence of non-steroidal anti-inflammatory drugs in rats. Eur. J. Drug Metabol. Pharmacokinet. 30: 235-241 (2005)

15. Fichtl B., Kurz H.: Binding of drugs to human muscle. Eur. J. Clin. Pharmacol. 14: 335-340 (1978)

16. Tesserommatis C., Saranteas T., Chatzijanni E., Anagnostopoulou S., Cotsiou A., Chatzi C.: Modifications of clonidine binding to rabbit liver protein under the influence of non-steroid-anti-inflammatory drugs in vitro. Eur. J. Drug Metabol. Pharmacokinet. 28: 245-247 (2003)

17. Tesseromatis C., Kotsiou A., Tsagataki M., Tigka E., Vovou J., Alevizou A., Perisanidis C., Saranteas T., Karakitsos D., Karabinis A., Kostopanagiotou G.: In vitro binding of lidocaine to liver tissue under the influence of propranolol: another mechanism of interaction? Eur. J. Drug Metabol. Pharmacokinet. 32: 213-217 (2007)

18. Tigka E., Kotsiou A., Saranteas T., Mourouzis J., Kostopanagiotou G., Tesseromatis C.: Clonidine changes lidocaine free concentrations in rat myocardium without affecting heart function measured by echocardiography. Eur. J. Drug Metabol. Pharmacokinet. 34: 229-232 (2009)

19. Kotsiou A., Potamianou A., Vovou J., Daskala J., Tesseromatis C.: The influence of various lipid patterns on rats under stress and nicotine exposure. Rev. Clin. Pharmacol. Pharmacokinet. Int. Ed. 22: 401-406 (2008)

20. Belpaire F.M., Bogaert M.G., Mussche M.M.: Influence of acute renal failure on the protein binding of drugs in animals and in man. Eur. J. Clin. Pharmacol. 11: 27-32 (1977)

21. Cistola D.P., Small D.M.: Fatty acid distribution in systems modeling the normal and diabetic human circulation. A 13C nuclear magnetic resonance study. J. Clin. Invest. 87: 1431-1441 (1991)

22. Viani A., Rizzo G., Carrai M., Pacifici G.M.: The effect of ageing on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment. Br. J. Clin. Pharmacol. 33: 299-304 (1992)

23. Panitsa G., Panitsas A., Potamianou A., Messari J., Vovou J., Tesseromatis C.: Impact of hyperlipidemia on the orbital bone cefotaxime levels in rats. Eur. J. Drug Metabol. Pharmacokinet. 1-5, (2010) article in press

24. Tesseromatis C., Tsopanakis C., Symeonoglou G., Loukissa M., Varonos D.: How harmless is FFA enhancement? Eur. J. Drug Metabol. Pharmacokinet. 21: 213-215 (1996)

25. Viani A., Rizzo G., Carrai M., Pacifici G.M.: The effect of ageing on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment. Br. J. Clin. Pharmacol. 33: 299-304 (1992)

26. Karakitsos D., Karabinis A., Kotsiou A.: C hanges of lidocaine levels in rat serum and tissue under stress and hyperlipidemic diets. Eur. J. Drug Metabol. Pharmacokinet. 34: 143-146 (2009)

27. Kotsiou A., Anagnostou M., Mourouzis C., Rallis G., Chantzi C., Tesseromatis C.: Impact of experimental trauma and niflumic acid administration on antimicrobials concentration in serum and mandible of rats. J. Musculoskelet. Neuronal. Interact. 6: 242-246 (2006)

28. Kotsiou A., Tsamouri M., Anagnostopoulou S., Tzivras M., Vairactaris E., Tesseromatis C.: H3 Propranolol serum levels following lidocaine administration in rats with CCl4 induced liver damage. Eur. J. Drug Metabol. Pharmacokinet. 31: 97-101 (2006)

29. Fichtl B., Nieciecki A., Walter K.: Tissue binding versus plasma binding of drugs: General principles and pharmacokinetic consequences. Adv. Drug Res. 20: 117-166 (1991)

30. Habig W.H., Pabst M.J., Fleischner G., Gatmaitan Z., Arias I.M., Jakoby W.B.: The identity of glutathione Stransferase B with ligandin, a major binding protein of liver. Proc. Natl. Acad. Sci. USA. 71: 3879-3882 (1974)

31. Saranteas T., Mourouzis C., Koumoura F., Tesseromatis C.: Effects of propranolol or paracetamol on lidocaine concentrations in serum and tissues. J. Oral Maxillofac. Surg. 61: 604-607 (2003)

32. Tesseromatis C., Fichtl B., Kurz H.: Binding of nonsteroid anti-inflammatory drugs and warfarin to liver tissue of rabbits in vitro. Eur. J. Drug Metabol. Pharmacokinet. 12: 161-167 (1987)

33. Tesseromatis C., Kotsiou A., et al.: Light induced changes in quinolone levels in rat serum and tissues. Eur. J. Drug Metabol. Pharmacokinet. 29: 231-233 (2004)

34. Benkestock K., Edlund P.O., Roeraade J.: Electrospray ionization mass spectrometry as a tool for determination of drug binding sites to human serum albumin by noncovalent interaction. Rapid Commun. Mass. Spectrom. 19: 1637-1643 (2005)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr